If rheumatoid factor (RF) is important in the pathogenesis of rheumatoid disease, then increased levels of RF should correlate with at least some aspect of disease activity. We have shown that high levels of serum IgG RF are strongly associated with the incidence of vasculitis but not with synovitis.' Studies of the temporal relationship of serum IgG RF levels to anticomplementary activity, C4 levels, and clinical features of vasculitis revealed that IgG RF levels and anticomplementary activity rose while C4 levels fell with clinical relapse and that the levels returned to normal with clinical improvement.2 Our interpretation of these results is that antigen-antibody complexes containing IgG (and probably in addition IgM3) RF activate complement, thereby initiating inflammation. It follows that RF-containing complexes capable of activating complement should be found in sera from rheumatoid patients with vasculitis but not synovitis. This was investigated by incubating sera from these patients with the F(ab)2 fragments of anti-human C3 attached to a solid matrix. C3 together with any material which has bound C3 should be taken up by the matrix. 
REAGENTS
IgG was prepared from normal human or rabbit serum (or from rabbit antisera) by precipitation with 20% sodium sulphate followed by elution from a diethylaminoethyl sepharose column and gel filtration on AcA 44 (LKB).
F(ab)2 fragments were prepared by digestion with pepsin followed by gel filtration on AcA 44. The efficacy of pepsin digestion was tested by radioassay with "25I-labelled goat antirabbit Fcy antibody.3
Small amounts of this antibody bound to wells coated with F(ab)2 preparations. By contrast high levels bound to wells coated with intact IgG.
Antisera specific to human y and ,t were prepared as described previously.3 Antihuman C3 was raised in rabbits by injecting them with their own erythrocytes which had been incubated in vitro with human serum, as described by Merry and colleagues.4 It was tested by 2-dimensional electrophoresis against ethylene diamine tetra-acetate treated human plasma and 2-day-old serum and by direct passive haemagglutination tests against human erythrocytes coated with various human C4 and C3 subcomponents. [5] [6] [7] The specificity of the antiserum was for C3c and C3d. It was passed down human IgG sepharose and the F(ab)2 fragments prepared before use.
Separation of sera by sucrose density gradient ultracentrifugation and the assay for IgG rheumatoid factor have been described.3
Results Sera from normal subjects and 4 groups of rheumatic patients were examined for their capacity to bind labelled heat-aggregated rabbit IgG after incubation on anti-C3 coated plates (Fig. 1) . Binding was detected in all (16/16) sera from patients with rheumatoid vasculitis but only in 6/28 sera from patients with synovitis, and these sera had relatively low activity. Sera from 9 normal subjects, 12 patients with ankylosing spondylitis, and 12 with SLE had little or no activity. Tests carried out with labelled heat-aggregated human IgG gave the same results. Some sera were frozen and thawed on a number of occasions before testing, but this did not alter their ability to take up labelled rabbit IgG on anti-C3 coated plates. It was important to test that the RF activity attached to the solid phase was bound by anti-C3 antibodies. This was done by comparing the uptake of labelled IgG on rabbit F(ab)2 anti-C3 plates, incubated with sera, with the uptake on normal rabbit F(ab)2 coated plates incubated with the same sera (Table 1) . Only one serum (from patient 1). bound more than 20% labelled IgG on normal F(ab)2 coated plates as compared with anti-C3 coated plates. So far we have tested over 250 sera from more than 50 patients, and serum from this patient is exceptional.
Experiments were set up to determine if the rheumatoid factor activity bound by anti-C3 from vasculitic sera was complexed in the sera before invitro testing. Table 2 shows that both RF activity bound by anti-C3 and IgG RF activity were precipitated by 2 5 % polyethylene glycol. Some sera were also ultracentrifuged on sucrose density gradients and the fractions tested for RF activity bound by anti-C3. The activity was restricted to the high (greater than 19 S) molecular weight containing fractions.
Tests were carried out to determine the isotype of the rheumatoid factor bound by anti-C3 from vasculitic sera. Sera were incubated with anti-C3 coated plates, the plates washed, and labelled rabbit IgG added to the plates alone or in the presence of rabbit F(ab)2 antihuman y, rabbit F(ab)2 antihuman A or normal rabbit F(ab)2. At low concentrations no effect was observed, but at 50 jig/ml (50 mg/l) (Table 3) IgG uptake was partially inhibited by anti-y, although part of this effect appears to be non anti-y specific, because there was some inhibition by normal F(ab)2. Curiously, anti-,u if anything increased IgG uptake.
Discussion
Previous results showed that high levels of IgG RF and anticomplementary activity are coincident in the sera of patients with rheumatoid vasculitis2 and also that complexes containing both IgG RF and IgM RF are present in these sera. 3 However, it could only be inferred that the complement-fixing complexes were those which contained RF. The method described here was devised to test this. We reasoned that complexes containing RF and complement (but not free RF or other RF containing complexes) would be bound by anti-C3 and bind IgG through any RF with unoccupied antigen-binding sites. On the other hand non-RF-containing complexes bound by anti-C3 would not take up IgG. Thus the results which show that IgG reacted strongly with anti-C3 coated plates incubated with sera from patients with vasculitis but poorly with sera from patients with synovitis support the hypothesis. This conclusion depends on 2 assumptions which were tested. The first is that the RF-containing complexes were bound to anti-C3 through its anti-C3 activity. The fact that little RF activity was bound by normal rabbit F(ab)2 coated plates supports this. The second is that the RF was complexed before addition to the plates rather than by non-RF-containing complexes being bound by anti-C3 and RF then binding to any IgG in the complex. The former seems likely, because 2 5 % polyethylene glycol, which precipitates neither monomeric IgG nor IgM' and should therefore separate free from unbound RF, did precipitate the RF activity bound by anti-C3. This finding, together with the fact that the RF activity bound by anti-C3 sedimented with material of molecular weight of over 900 000, also suggests that C3 was bound to the RF-containing complex before in-vitro testing, because free C3 (MW 200 000) should be separated from the complex by these procedures.
Attempts to determine the isotype(s) of the RF which was bound by anti-C3 from vasculitis sera were less successful. 
